145 related articles for article (PubMed ID: 7897635)
1. A new point mutation involving a highly conserved leucine in the Btk SH2 domain in a family with X linked agammaglobulinaemia.
Ohashi Y; Tsuchiya S; Konno T
J Med Genet; 1995 Jan; 32(1):77-8. PubMed ID: 7897635
[No Abstract] [Full Text] [Related]
2. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
[TBL] [Abstract][Full Text] [Related]
3. Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families.
Zhu Q; Zhang M; Winkelstein J; Chen SH; Ochs HD
Hum Mol Genet; 1994 Oct; 3(10):1899-900. PubMed ID: 7849721
[No Abstract] [Full Text] [Related]
4. Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase.
Vorechovský I; Luo L; de Saint Basile G; Hammarström L; Webster AD; Smith CI
Hum Mol Genet; 1995 Dec; 4(12):2403-5. PubMed ID: 8634718
[No Abstract] [Full Text] [Related]
5. SSCP at the BTK locus.
Vorechovský I
Hum Mol Genet; 1994 Jun; 3(6):1031. PubMed ID: 7951224
[No Abstract] [Full Text] [Related]
6. Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.
Gaspar HB; Ferrando M; Caragol I; Hernandez M; Bertran JM; De Gracia X; Lester T; Kinnon C; Ashton E; Espanol T
Clin Exp Immunol; 2000 May; 120(2):346-50. PubMed ID: 10792386
[TBL] [Abstract][Full Text] [Related]
7. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
Schuster V; Seidenspinner S; Kreth HW
Am J Med Genet; 1996 May; 63(1):318-22. PubMed ID: 8723128
[TBL] [Abstract][Full Text] [Related]
8. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).
Jin H; Webster AD; Vihinen M; Sideras P; Vorechovsky I; Hammarstróm L; Bernatowska-Matuszkiewicz E; Smith CI; Bobrow M; Vetrie D
Hum Mol Genet; 1995 Apr; 4(4):693-700. PubMed ID: 7633420
[TBL] [Abstract][Full Text] [Related]
9. Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.
Ohta Y; Haire RN; Litman RT; Fu SM; Nelson RP; Kratz J; Kornfeld SJ; de la Morena M; Good RA; Litman GW
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9062-6. PubMed ID: 8090769
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ
J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269
[TBL] [Abstract][Full Text] [Related]
11. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
[TBL] [Abstract][Full Text] [Related]
12. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
Hagemann TL; Chen Y; Rosen FS; Kwan SP
Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
[TBL] [Abstract][Full Text] [Related]
13. Maternal germinal mosaicism of X-linked agammaglobulinemia.
Sakamoto M; Kanegane H; Fujii H; Tsukada S; Miyawaki T; Shinomiya N
Am J Med Genet; 2001 Mar; 99(3):234-7. PubMed ID: 11241495
[TBL] [Abstract][Full Text] [Related]
14. Identification of a new Bruton's tyrosine kinase (BTK) mutation associated with a mild phenotype in a child with X-linked agammaglobulinemia (XLA).
Staehelin F; Kühne T
Clin Lab Haematol; 2000 Apr; 22(2):123-5. PubMed ID: 10792406
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mutations, including a novel regulatory defect in the first intron, in Bruton's tyrosine kinase gene from seven Korean X-linked agammaglobulinemia families.
Jo EK; Kanegane H; Nonoyama S; Tsukada S; Lee JH; Lim K; Shong M; Song CH; Kim HJ; Park JK; Miyawaki T
J Immunol; 2001 Oct; 167(7):4038-45. PubMed ID: 11564824
[TBL] [Abstract][Full Text] [Related]
16. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.
Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J
Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697
[TBL] [Abstract][Full Text] [Related]
17. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
[TBL] [Abstract][Full Text] [Related]
18. Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.
Saffran DC; Parolini O; Fitch-Hilgenberg ME; Rawlings DJ; Afar DE; Witte ON; Conley ME
N Engl J Med; 1994 May; 330(21):1488-91. PubMed ID: 8164701
[No Abstract] [Full Text] [Related]
19. Structural basis of SH2 domain mutations in X-linked agammaglobulinemia.
Vihinen M; Nilsson L; Smith CI
Biochem Biophys Res Commun; 1994 Dec; 205(2):1270-7. PubMed ID: 7528500
[TBL] [Abstract][Full Text] [Related]
20. Discordant phenotype in siblings with X-linked agammaglobulinemia.
Bykowsky MJ; Haire RN; Ohta Y; Tang H; Sung SS; Veksler ES; Greene JM; Fu SM; Litman GW; Sullivan KE
Am J Hum Genet; 1996 Mar; 58(3):477-83. PubMed ID: 8644706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
